Novo Nordisk's late bid to hijack Pfizer's takeover of US obesity biotech Metsera marks an aggressive shift from the Danish ...

The lawsuit escalates an unusual, high-profile battle between two large pharmaceutical companies over ownership of a coveted developer of obesity drugs.

Pfizer has filed a lawsuit against Metsera and Novo Nordisk, saying Metsera breached its merger agreement obligations.

Pfizer has decided to sue Metsera and Novo over $8.5B bid, citing antitrust risks and asserting regulatory advantage.

Pfizer is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera. New York-based ...

Pfizer has sued Metsera and Novo Nordisk, alleging a breach of merger agreement over a rival $8.5 billion bid for Metsera's obesity drug pipeline.

In a rapidly changing and uncertain world, Canada's new government is focused on what we can control. We are protecting our communities and our country. We are building our economy with major projects ...

Trump-Xi truce talks, Nvidia’s $5T milestone, Big Tech earnings, and Musk’s $1T showdown headline a packed week.

On Saturday, October 25, 2025, ComplexCon hosted the highly anticipated live return of VERZUZ with a legendary face-off between Cash Money Records and No Limit Records. Two of New Orlean's most iconic ...

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker.

This data dropped around the same time as the beginning of a weight loss feud between Pfizer and Novo Nordisk after the ...